<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-42398" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cryoglobulinemic Vasculitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Davuluri</surname>
            <given-names>Srijana</given-names>
          </name>
          <aff>Santa Clara Valley Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vaqar</surname>
            <given-names>Sarosh</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Srijana Davuluri declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sarosh Vaqar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-42398.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Cryoglobulinemic vasculitis is an immune complex-mediated inflammation of blood vessels. It is usually seen as part of other diseases and is the most common extrahepatic manifestation in patients with hepatitis C. This activity reviews the evaluation and management of cryoglobulinemic vasculitis and highlights the role of the interprofessional team in managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of cryoglobulinemic vasculitis.</p></list-item><list-item><p>Outline the appropriate evaluation of cryoglobulinemic vasculitis.</p></list-item><list-item><p>Review the treatment options available for cryoglobulinemic vasculitis.</p></list-item><list-item><p>Describe the interprofessional team strategies for improving care coordination and communication to advance cryoglobulinemic vasculitis and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=42398&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=42398">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-42398.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Cryoglobulinemic vasculitis&#x000a0;(CryoVas) is an immune complex-mediated inflammation of the small and medium-sized blood vessels, involving complement activation.<xref ref-type="bibr" rid="article-42398.r1">[1]</xref>&#x000a0;In 1933, Wintrobe and Buell discovered &#x0201c;cryoprecipitate&#x0201d; in the blood from a patient suffering from multiple myeloma. In 1947, Lerner and Watson coined the term &#x0201c;cryoglobulin&#x0201d;&#x000a0;and it applies to immunoglobulins that can precipitate in vitro, from plasma as well as serum when the temperature falls below 37 C and re-solubilize on warming.<xref ref-type="bibr" rid="article-42398.r2">[2]</xref>&#x000a0;CryoVas is famously associated with Hepatitis C (Hep-C) as well as some B-cell related blood dyscrasias.</p>
      </sec>
      <sec id="article-42398.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Cryoglobulins can be detectable in the serum of patients with several inflammatory conditions; however, they do not always lead to the disease.&#x000a0;The real mechanism of cryoprecipitation is complicated and still not completely understood. It is sometimes attributed to the intrinsic properties of the Immunoglobulin components.<xref ref-type="bibr" rid="article-42398.r3">[3]</xref><xref ref-type="bibr" rid="article-42398.r4">[4]</xref> Cryoglobulinemic vasculitis can rarely occur by itself and is usually secondary to other diseases. Brouet classified cryoglobulins into 3 major groups based on the immunoglobulin type&#x000a0;<xref ref-type="bibr" rid="article-42398.r5">[5]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Type 1 cryoglobulins</bold> comprise monoclonal immunoglobulins, usually IgM, less frequently IgG, IgA, or light chains. Although rare, they are also found in plasma cell dyscrasias like multiple myeloma and monoclonal gammopathy of unknown significance, B cell diseases like Waldenstorms macroglobulinemia, lymphoproliferative diseases like Non-Hodgkin lymphoma and chronic lymphocytic leukemia.<xref ref-type="bibr" rid="article-42398.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Type 2 cryoglobulins</bold> consist of monoclonal IgM with rheumatoid factor (RF) activity and polyclonal IgG.</p>
          </list-item>
          <list-item>
            <p><bold>Type 3 cryoglobulins</bold> involve polyclonal IgM with RF activity and polyclonal IgG.</p>
          </list-item>
          <list-item>
            <p>Newer techniques like immunoblotting have helped identify a novel mixed cryoglobulin, which is called type II to III (it is type II cryoglobulin with microheterogeneity) as it has a simultaneous presence of oligoclonal IgM and polyclonal IgG.<xref ref-type="bibr" rid="article-42398.r7">[7]</xref> This type has not been studied in detail.</p>
          </list-item>
        </list>
        <p>RF activity denotes the binding capacity of IgM to the Fc fragment of IgG. Type 2 and Type 3 are referred to as mixed cryoglobulins. They are commonly associated with infections, autoimmune diseases, and lymphoproliferative disorders:</p>
        <list list-type="bullet">
          <list-item>
            <p>Among infections, Hepatitis C is the most common.<xref ref-type="bibr" rid="article-42398.r8">[8]</xref><xref ref-type="bibr" rid="article-42398.r9">[9]</xref>&#x000a0;Other infections include Hepatitis B, Cytomegalovirus, Epstein B virus, Parvovirus B19, HIV, pyogenic bacterial infections, candidiasis, visceral leishmaniasis, and <italic toggle="yes">Coxiella burnetii.</italic><xref ref-type="bibr" rid="article-42398.r10">[10]</xref><xref ref-type="bibr" rid="article-42398.r11">[11]</xref><xref ref-type="bibr" rid="article-42398.r12">[12]</xref><xref ref-type="bibr" rid="article-42398.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p>Autoimmune conditions include systemic lupus erythematosus and Sjogren syndrome.<xref ref-type="bibr" rid="article-42398.r14">[14]</xref><xref ref-type="bibr" rid="article-42398.r15">[15]</xref>&#x000a0;Giuggioli et al. have found that 2.8% of systemic sclerosis (SSc) cases can have cryoglobulins, of which 1.6% can have manifestations, and they are linked to HCV.<xref ref-type="bibr" rid="article-42398.r16">[16]</xref><xref ref-type="bibr" rid="article-42398.r15">[15]</xref>&#x000a0;This overlap syndrome can cause severe vasculopathy symptoms like non-healing ulcers with gangrene.</p>
          </list-item>
          <list-item>
            <p>Lymphoproliferative disorders like diffuse large B cell lymphoma and Non-Hodgkin lymphoma.<xref ref-type="bibr" rid="article-42398.r17">[17]</xref>&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-42398.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The prevalence of cryoglobulinemic vasculitis is rare (1:100,000) with significant geographic variations. It is commonly seen in patients aged 45 to 65 years with a maximum incidence in women (sex ratio is 2-3:1).<xref ref-type="bibr" rid="article-42398.r18">[18]</xref> The disease is more common in southern Europe, which might be related to the endemic prevalence of hepatitis C.<xref ref-type="bibr" rid="article-42398.r19">[19]</xref> 20% to 50% of patients with hepatitis C can have serum cryoglobulins; however, only up to one-third of these develop clinical cryoglobulinemic syndrome.<xref ref-type="bibr" rid="article-42398.r20">[20]</xref></p>
      </sec>
      <sec id="article-42398.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Type 1 cryoglobulins usually cause hyperviscosity syndrome or vasculitis.<xref ref-type="bibr" rid="article-42398.r21">[21]</xref></p>
        <p>Mixed cryoglobulins can be present in normal healthy individuals without causing symptoms.<xref ref-type="bibr" rid="article-42398.r22">[22]</xref>&#x000a0;It has been hypothesized that heavy chain glycosylation and other stereotactic properties can influence the activation of complement and Fc receptor of macrophage.<xref ref-type="bibr" rid="article-42398.r23">[23]</xref>&#x000a0;There is a role of genetic factors like the presence of BAFF (B-lymphocyte activating factor) and Fc receptor variants, especially in Hepatitis C infected individuals.<xref ref-type="bibr" rid="article-42398.r24">[24]</xref>&#x000a0;It is hypothesized that Hepatitis C envelope protein E2 can bind with the B lymphocyte CD81 receptor, thereby acting as an antigenic stimulus. This leads to the formation of antibodies and the resulting antigen-antibody complexes that get deposited in vessel walls.<xref ref-type="bibr" rid="article-42398.r25">[25]</xref><xref ref-type="bibr" rid="article-42398.r26">[26]</xref>&#x000a0;Few cases of sustained vasculitis despite viral clearance&#x000a0;indicate that the B cell clones persist despite antigen clearance.<xref ref-type="bibr" rid="article-42398.r27">[27]</xref><xref ref-type="bibr" rid="article-42398.r28">[28]</xref><xref ref-type="bibr" rid="article-42398.r29">[29]</xref><xref ref-type="bibr" rid="article-42398.r30">[30]</xref><xref ref-type="bibr" rid="article-42398.r31">[31]</xref>&#x000a0;It was also observed that B cell-activating factor (BAFF) levels increase despite the completion of antiviral treatment in patients with HCV&#x000a0;leading to relapses.<xref ref-type="bibr" rid="article-42398.r32">[32]</xref></p>
      </sec>
      <sec id="article-42398.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Among type 1 cryoglobulinemic vasculitis, occlusion of vessels can occasionally occur with eosinophilic precipitates. It can be distinguished from fibrin with periodic acid Schiff stain.<xref ref-type="bibr" rid="article-42398.r33">[33]</xref>&#x000a0;Leukocytoclastic vasculitis involving the small vessels is the major histopathology in Hep-C associated cutaneous lesions, and vessels from the dermis up to the subcutaneous fat layer can be affected.<xref ref-type="bibr" rid="article-42398.r26">[26]</xref>&#x000a0;Immunofluorescence in cryoglobulinemic vasculitis reveals complement and immunoglobulin deposition. The immunoglobulins identified on immunofluorescence&#x000a0;vary for each type of cryoglobulinemic vasculitis, for example, in mixed cryoglobulinemic vasculitis, both IgG and IgM deposition along with complements will be seen, while in type I, deposition of a single type of immunoglobulin (most commonly IgM) with complements is seen.&#x000a0;Agnello V et al. have demonstrated that the Hep-C virus is concentrated in the cryoprecipitate compared to its presence in the serum.<xref ref-type="bibr" rid="article-42398.r34">[34]</xref>&#x000a0;In another study, they have demonstrated the presence of HCV particles in the vascular endothelium of skin lesions.<xref ref-type="bibr" rid="article-42398.r35">[35]</xref></p>
        <p>Membranoproliferative glomerulonephritis is the frequent type of kidney involvement in cryoVas whether or not related to Hep-C.<xref ref-type="bibr" rid="article-42398.r36">[36]</xref><xref ref-type="bibr" rid="article-42398.r37">[37]</xref>&#x000a0;Mesangial proliferative glomerulonephritis and focal proliferative glomerulonephritis are occasionally found.<xref ref-type="bibr" rid="article-42398.r38">[38]</xref>&#x000a0;Luminal thrombi in capillary walls have also been seen.<xref ref-type="bibr" rid="article-42398.r39">[39]</xref></p>
      </sec>
      <sec id="article-42398.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Identification of cryoglobulinemic vasculitis clinically is important because of its potential life-threatening and limb depriving complications.<xref ref-type="bibr" rid="article-42398.r38">[38]</xref></p>
        <p>Type 1 cryoglobulinemia has frequent manifestations of skin like Raynaud&#x02019;s phenomenon, ulcers, gangrene, and rarely involves kidneys.<xref ref-type="bibr" rid="article-42398.r6">[6]</xref><xref ref-type="bibr" rid="article-42398.r40">[40]</xref></p>
        <p>In mixed cryoglobulinemia, the skin, musculoskeletal system, and kidneys are frequently affected. Historically, Meltzer has described the triad of arthralgias, purpura, and weakness.<xref ref-type="bibr" rid="article-42398.r41">[41]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Cutaneous lesions include palpable purpura in dependent areas, digital ulcers, gangrene.<xref ref-type="bibr" rid="article-42398.r42">[42]</xref></p>
          </list-item>
          <list-item>
            <p>Musculoskeletal manifestations are arthralgias in hands and knees with no arthritis.</p>
          </list-item>
          <list-item>
            <p>Neurological symptoms are commonly bilateral and symmetrical. It can be distal sensory or sensorimotor polyneuropathy.<xref ref-type="bibr" rid="article-42398.r43">[43]</xref><xref ref-type="bibr" rid="article-42398.r44">[44]</xref></p>
          </list-item>
          <list-item>
            <p>Renal involvement generally means worse prognosis and presents with hematuria, proteinuria, worsening renal function.</p>
          </list-item>
        </list>
        <p>Other rare manifestations are:</p>
        <list list-type="bullet">
          <list-item>
            <p>CNS vasculitis which can present with hemiplegia, coma, encephalopathy, or seizures.<xref ref-type="bibr" rid="article-42398.r38">[38]</xref><xref ref-type="bibr" rid="article-42398.r45">[45]</xref><xref ref-type="bibr" rid="article-42398.r38">[38]</xref></p>
          </list-item>
          <list-item>
            <p>Gastrointestinal - mesenteric vasculitis, duodenal vasculitis, or pancreatitis which present with abdominal pain.<xref ref-type="bibr" rid="article-42398.r29">[29]</xref><xref ref-type="bibr" rid="article-42398.r38">[38]</xref><xref ref-type="bibr" rid="article-42398.r29">[29]</xref></p>
          </list-item>
          <list-item>
            <p>Pulmonary hemorrhage can also be a rare presentation&#x000a0;with hemoptysis, dyspnea, or respiratory failure as first signs.<xref ref-type="bibr" rid="article-42398.r38">[38]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hypertrophic cardiomyopathy&#x000a0;presents with dyspnea on exertion.<xref ref-type="bibr" rid="article-42398.r46">[46]</xref></p>
          </list-item>
          <list-item>
            <p>Pericarditis, coronary vasculitis, and heart failure.</p>
          </list-item>
          <list-item>
            <p>Hyperviscosity syndrome</p>
          </list-item>
          <list-item>
            <p>Dry eyes and dry mouth</p>
          </list-item>
          <list-item>
            <p>Parotitis, which is usually bilateral</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-42398.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Baseline complete blood counts, renal function, urinalysis, urine microscopy, and&#x000a0;urine protein evaluation (urine protein by creatinine ratio, or 24-hour urine protein) should be performed in all patients with a suspicion of cryoglobulinemic vasculitis. Markers of inflammation, including erythrocyte sedimentation rate and C-reactive protein, may be elevated.</p>
        <p>
<bold>Cryoglobulin Detection</bold>
</p>
        <p>Accurate detection of cryoglobulins can be difficult, and false-positive and false-negative values are not uncommon. The blood shall be drawn into preheated tubes at 37&#x000b0;C until coagulated&#x000a0;followed by centrifugation after which, it should be stored at 4&#x000b0;C for 7 days. A white precipitate indicates the presence of cryoglobulins at the bottom of the tube, which dissolves when the tube is rewarmed to 37&#x000b0;C. Quantification of cryoglobulins shall be determined by measuring the percentage of cryoglobulins. Cryoglobulins shall be then characterized by immunologic methods, including immunofixation and immunodiffusion, which help identify the type of immunoglobulin involved. As noted above, false-positive and false-negative test results are common and repeated testing increases accuracy.&#x000a0;</p>
        <p>
<bold>Serologic Testing</bold>
</p>
        <p>Rheumatoid factor testing shall be pursued in all patients with a suspicion of cryoglobulinemic vasculitis. Complement levels shall be tested as well and will usually indicate low serum C4 and normal C3. Serological workup including ANA, Anti-SSA, Anti-SSB, Anti-Ds-DNA, Anti-Smith, and other autoantibodies to detect underlying autoimmune diseases such as systemic lupus erythematosus or Sjogren syndrome shall be considered based on the patient's clinical presentation.&#x000a0;</p>
        <p>
<bold>Infection Workup</bold>
</p>
        <p>Viral hepatitis screening, including anti-hepatitis C viral antibody, hepatitis C viral RNA PCR, hepatitis B surface antigen, hepatitis B surface antibody, and hepatitis B core antibody, shall be performed to&#x000a0;detect underlying viral hepatitis. Workup for other potential infectious etiology can be considered on an individual basis.</p>
        <p>
<bold>Malignancy Workup</bold>
</p>
        <p>Complete blood count with differential, peripheral smear, flow cytometry for evaluation of underlying leukemia or lymphoma should be considered. Serum protein electrophoresis and quantitative immunoglobulins shall be considered to rule out multiple myeloma or monoclonal gammopathy of unknown significance. Bone marrow or lymph node biopsy may be needed in some cases.</p>
        <p>
<bold>Pathological Workup</bold>
</p>
        <p>Skin biopsy of cutaneous lesions can be done (and is recommended if initial presentation). Skin biopsy shall be sent for histopathology and for immunofluorescence to identify immune-complexes.&#x000a0;In cases of suspicion of renal involvement, renal biopsy shall be considered.</p>
      </sec>
      <sec id="article-42398.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of cryoglobulinemic vasculitis can require combined inputs from different specialties like hepatologists, rheumatologists, and hematologists, depending on the underlying disease present and the severity of the illness.<xref ref-type="bibr" rid="article-42398.r47">[47]</xref>. The treatment is dictated by the underlying associated etiology, disease severity, and organ involvement. Treatment should be aimed at suppressing B-cell proliferation,&#x000a0;eradicating hepatitis C viral infection when present, and reducing circulating immune complex-mediated damage.</p>
        <p>
<bold>Immunosuppressive Therapy</bold>
</p>
        <p>In patients with life-threatening or severe manifestations such as mesenteric vasculitis, pulmonary hemorrhage, and rapidly progressing glomerulonephritis, treatment with plasmapheresis and high dose corticosteroids is the first-line therapy. Immunosuppression with rituximab or cyclophosphamide in combination with plasmapheresis and high-dose corticosteroids reduces the risk of relapse. Antiviral therapy for hepatitis C virus is not considered first-line in life-threatening manifestations as the immune process can become independent of viral antigen triggering. Milder manifestations, including skin rash/ulcers, glomerulonephritis, and peripheral neuropathy all respond well to corticosteroids and rituximab with resolution in the symptoms within 6 months of starting rituximab.<xref ref-type="bibr" rid="article-42398.r48">[48]</xref><xref ref-type="bibr" rid="article-42398.r49">[49]</xref> However, repeat courses of rituximab may be needed to maintain remission.<xref ref-type="bibr" rid="article-42398.r47">[47]</xref>&#x000a0;Regimens containing cyclophosphamide and corticosteroids were also tried in this&#x000a0;group. Patients who have associated other autoimmune diseases such as systemic lupus erythematosus or Sjogren syndrome also usually respond well to corticosteroids. Immunosuppressive therapy, such as cyclophosphamide for more&#x000a0;serious manifestations, methotrexate for milder manifestations,&#x000a0;and mycophenolate mofetil for refractory cases, can be used.<xref ref-type="bibr" rid="article-42398.r50">[50]</xref><xref ref-type="bibr" rid="article-42398.r51">[51]</xref>&#x000a0;</p>
        <p>
<bold>Antiviral therapy:</bold>
</p>
        <p>In patients with cryoglobulinemic vasculitis associated with hepatitis C infection who have milder manifestation, simultaneous treatment of immunosuppressive therapy, as documented above with antiviral therapy (for hepatitis C viral infection), has been shown to be effective and is the cornerstone of management.&#x000a0;Antiviral therapy involving a combination of ribavirin with direct-acting agents like sofosbuvir has shown to be effective.<xref ref-type="bibr" rid="article-42398.r52">[52]</xref><xref ref-type="bibr" rid="article-42398.r53">[53]</xref>&#x000a0;Rituximab, in combination with antiviral therapy involving interferon, seemed to show better clinical outcomes compared to antiviral treatment alone in some trials.<xref ref-type="bibr" rid="article-42398.r54">[54]</xref><xref ref-type="bibr" rid="article-42398.r55">[55]</xref>&#x000a0;Rituximab also showed quicker response rates and better renal relapse rates compared to antiviral therapy alone.<xref ref-type="bibr" rid="article-42398.r56">[56]</xref>&#x000a0;It has helped achieve remission in cases where antiviral therapy has failed.<xref ref-type="bibr" rid="article-42398.r57">[57]</xref><xref ref-type="bibr" rid="article-42398.r58">[58]</xref>&#x000a0;Although sustained virologic response seems to correlate well with remission of cryoglobulinemic vasculitis, there are rare instances of persistent cryoglobulins and related symptoms despite viral clearance.<xref ref-type="bibr" rid="article-42398.r31">[31]</xref><xref ref-type="bibr" rid="article-42398.r30">[30]</xref><xref ref-type="bibr" rid="article-42398.r59">[59]</xref><xref ref-type="bibr" rid="article-42398.r30">[30]</xref>&#x000a0;This has been attributed to the B cell clonal stimulation, and therefore long term follow-up is essential.</p>
        <p>
<bold>Other Therapeutic Considerations</bold>
</p>
        <p>Cryoglobulinemic vasculitis associated with B-cell dyscrasias and lymphoproliferative diseases can be treated with the disease-specific chemotherapy and occasionally requires immunosuppression. Cyclophosphamide, dexamethasone, and thalidomide can treat cutaneous symptoms (with no renal involvement).<xref ref-type="bibr" rid="article-42398.r60">[60]</xref>&#x000a0;Bortezomib has been successfully used to treat cryoglobulinemic vasculitis related to multiple myeloma and MGUS.<xref ref-type="bibr" rid="article-42398.r6">[6]</xref><xref ref-type="bibr" rid="article-42398.r61">[61]</xref>&#x000a0;It was found to be effective in treating patients with concomitant cryoglobulinemic vasculitis and cold agglutinin disease.<xref ref-type="bibr" rid="article-42398.r62">[62]</xref>&#x000a0;It was also used in rituximab resistant disease with favorable results.<xref ref-type="bibr" rid="article-42398.r63">[63]</xref>&#x000a0;Plasmapheresis is done in life-threatening complications like renal failure or severe cutaneous necrosis.<xref ref-type="bibr" rid="article-42398.r21">[21]</xref></p>
        <p>In patients with cryoglobulinemic vasculitis and hepatitis B infection, treatment with rituximab alone without antiviral therapy can lead to severe reactivation of hepatitis B. It is recommended that antiviral therapy be started before or concomitantly with immunosuppressive therapy (especially rituximab) in these patients.<xref ref-type="bibr" rid="article-42398.r64">[64]</xref><xref ref-type="bibr" rid="article-42398.r65">[65]</xref></p>
        <p>Other infections causing mixed CryoVas can be treated with specific antimicrobial therapy for sustained remission, immunosuppression is to be used only in refractory cases.<xref ref-type="bibr" rid="article-42398.r10">[10]</xref></p>
        <p>IV immunoglobulin treatment is contraindicated in CryoVas as it can cause immune complex precipitation leading to multi-organ failure.<xref ref-type="bibr" rid="article-42398.r66">[66]</xref></p>
        <p>TNF-alpha inhibitors are not to be used in CryoVas as they have shown to cause early relapses and occasional worsening of neuropathy and skin ulcers.<xref ref-type="bibr" rid="article-42398.r67">[67]</xref><xref ref-type="bibr" rid="article-42398.r68">[68]</xref></p>
      </sec>
      <sec id="article-42398.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Systemic lupus erythematosus can cause cutaneous vasculitis, cytopenias, arthralgias, positive RF, and glomerulonephritis. Further, there can be overlap with patients with underlying systemic lupus erythematosus developing cryoglobulinemic vasculitis. Systemic lupus erythematosus is usually associated with low complements, both C3 and C4, and not just isolated C4 depletion. Serum cryoglobulin detection and pathological evaluation are critical in differentiating these two conditions.</p>
        <p>Rheumatoid arthritis is associated with joint pain and a positive RF. Rarely, leukocytoclastic vasculitis can be seen in rheumatoid arthritis as well. However, rheumatoid arthritis is associated with the presence of inflammatory arthritis and synovitis, which is usually absent in cryoglobulinemic vasculitis, where patients have arthralgias but usually lacks true synovitis. Further, anti-CCP antibodies are specific for rheumatoid arthritis and are not seen in cryoglobulinemic vasculitis. Renal involvement is rare in rheumatoid arthritis. Complements are usually normal in rheumatoid arthritis. Cryoglobulins will be absent.</p>
        <p>Systemic sclerosis can cause cutaneous manifestations like digital ulcers and gangrene. However, other clinical features of systemic sclerosis, including sclerodactyly, calcinosis, interstitial lung disease, gastrointestinal dysmotility, are not seen in cryoglobulinemic vasculitis. Renal involvement in systemic sclerosis is rare and is manifested as scleroderma renal crisis which is different from cryoglobulinemic vasculitis induced glomerulonephritis. Both of these can be differentiated by kidney biopsy.</p>
        <p>Henoch Schlein purpura (HSP) causes palpable purpura in lower extremities but can be differentiated by immunofluorescence of skin biopsy. In&#x000a0;HSP, immunofluorescence usually shows the deposition of IgA and not immune complexes.</p>
      </sec>
      <sec id="article-42398.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Mortality rates for cryoglobulinemic vasculitis are higher compared to the general population.<xref ref-type="bibr" rid="article-42398.r69">[69]</xref>&#x000a0;Most deaths occur due to renal involvement or widespread vasculitis, especially gastrointestinal involvement. The use of antiviral treatment results in better outcomes; however, several poor prognostic factors have been documented.</p>
        <p>Poor prognostic features of cryoglobulinemic vasculitis in association with hepatitis C viral infection include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Presence of severe liver fibrosis at the time of diagnosis</p>
          </list-item>
          <list-item>
            <p>In the absence of liver fibrosis, five-factor score (FFS) developed by Guillevin et al.,&#x000a0;which takes into account- proteinuria greater than 1 g/day, serum creatinine greater than 150 micromol/L, cardiomyopathy, gastrointestinal and CNS involvement, seemed to correlate with prognosis.<xref ref-type="bibr" rid="article-42398.r70">[70]</xref><xref ref-type="bibr" rid="article-42398.r71">[71]</xref></p>
          </list-item>
          <list-item>
            <p>Gastrointestinal vasculitis seemed to have a poor prognosis.<xref ref-type="bibr" rid="article-42398.r29">[29]</xref><xref ref-type="bibr" rid="article-42398.r72">[72]</xref></p>
          </list-item>
        </list>
        <p>The prognostic factors in non-infectious mixed cryoglobulinemic vasculitis include CryoVas score (age greater than 65, pulmonary and gastrointestinal involvement, and renal failure).<xref ref-type="bibr" rid="article-42398.r73">[73]</xref><xref ref-type="bibr" rid="article-42398.r74">[74]</xref></p>
        <p>Poor prognostic features in type 1 cryoglobulinemia are old age and renal involvement. Sign of neuropathy on presentation was also found to be one of the poor prognostic indicators in a retrospective study.<xref ref-type="bibr" rid="article-42398.r75">[75]</xref></p>
      </sec>
      <sec id="article-42398.s12" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>B-cell lymphomas are commonly found in mixed&#x000a0;cryoglobulinemic vasculitis patients.<xref ref-type="bibr" rid="article-42398.r76">[76]</xref>&#x000a0;Treatment is directed against B-cell lymphoma.</p>
          </list-item>
          <list-item>
            <p>The presence of mixed cryoglobulinemic vasculitis in Hep-C infected individuals is associated with increased mortality,&#x000a0;whereas, in other infections, prognosis relies on the infection itself.<xref ref-type="bibr" rid="article-42398.r42">[42]</xref></p>
          </list-item>
          <list-item>
            <p>The major causes of death include Hep-C related hepatopathy and severe infections related to immunosuppressive therapy used.</p>
          </list-item>
          <list-item>
            <p>Multiorgan involvement can occur, which is always a poor prognostic sign.<xref ref-type="bibr" rid="article-42398.r66">[66]</xref><xref ref-type="bibr" rid="article-42398.r77">[77]</xref><xref ref-type="bibr" rid="article-42398.r38">[38]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-42398.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Cryoglobulinemic vasculitis can result in debilitating symptoms like painful neuropathy or complications like gangrene requiring amputations. It is also associated with an increase in mortality and sometimes has many relapses throughout the disease process. Hence it is important to initiate appropriate treatment early in the disease course and have a long term follow up.</p>
      </sec>
      <sec id="article-42398.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Cryoglobulins in the serum can interfere with other lab detection tests like troponin assays and should be kept in mind when there are no clinical features.<xref ref-type="bibr" rid="article-42398.r78">[78]</xref></p>
        <p>A patient with fever, valvular heart disease, negative cultures in the setting of mixed cryoglobulinemia must be evaluated for Q fever.</p>
      </sec>
      <sec id="article-42398.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Although cryoglobulinemic vasculitis is predominantly associated with Hepatitis C virus infection, various specialties are involved in the management of these patients. Gastroenterologists play a role in initiating antiviral therapy along with monitoring the viral load for hepatitis C. Dermatologists are involved when a skin biopsy is needed. The pathologist also plays a role as he could suggest the diagnosis based on labs and biopsies. Rheumatologists are frequently involved in managing severe or resistant cases as they have more experience with immunosuppressive therapies. When cryoglobulinemic vasculitis is related to non-Hepatitis C infections, we need appropriate antibiotic therapy to treat the infection, which may be acting as a trigger. Pharmacists help adjust the doses of medications based on renal function and in monitoring drug interactions. Patients can have complications like multiorgan failure, requiring critical care, and the nursing role is immense in taking care of these patients and in educating the families. Wound care is important as the patients frequently have nonhealing ulcers and gangrene when general surgeons help salvaging the limbs. Hematologists play a major role in treating hematologic malignancies and when complications like lymphoma arise. Primary care physicians play a major role in identifying the disease, as it frequently presents with common outpatient complaints like a purpuric rash, arthralgias, and neuropathic pain. They also play a key role as a mediator between the various specialties, while advocating for the patient and keeping them well-informed. [Level 5]</p>
      </sec>
      <sec id="article-42398.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=42398&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=42398">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/blood-disorders/cryoglobulinemic-vasculitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=42398">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/42398/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=42398">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-42398.s17">
        <title>References</title>
        <ref id="article-42398.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferri</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Mixed cryoglobulinemia.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2008</year>
            <month>Sep</month>
            <day>16</day>
            <volume>3</volume>
            <fpage>25</fpage>
            <pub-id pub-id-type="pmid">18796155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LERNER</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>WATSON</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Studies of cryoglobulins; unusual purpura associated with the presence of a high concentration of cryoglobulin (cold precipitable serum globulin).</article-title>
            <source>Am J Med Sci</source>
            <year>1947</year>
            <month>Oct</month>
            <volume>214</volume>
            <issue>4</issue>
            <fpage>410</fpage>
            <page-range>410-5</page-range>
            <pub-id pub-id-type="pmid">20266939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Middaugh</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Litman</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Atypical glycosylation of an IgG monoclonal cryoimmunoglobulin.</article-title>
            <source>J Biol Chem</source>
            <year>1987</year>
            <month>Mar</month>
            <day>15</day>
            <volume>262</volume>
            <issue>8</issue>
            <fpage>3671</fpage>
            <page-range>3671-3</page-range>
            <pub-id pub-id-type="pmid">3102493</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tomana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schrohenloher</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Koopman</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Alarc&#x000f3;n</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases.</article-title>
            <source>Arthritis Rheum</source>
            <year>1988</year>
            <month>Mar</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>333</fpage>
            <page-range>333-8</page-range>
            <pub-id pub-id-type="pmid">3358797</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brouet</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Clauvel</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Danon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Seligmann</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Biologic and clinical significance of cryoglobulins. A report of 86 cases.</article-title>
            <source>Am J Med</source>
            <year>1974</year>
            <month>Nov</month>
            <volume>57</volume>
            <issue>5</issue>
            <fpage>775</fpage>
            <page-range>775-88</page-range>
            <pub-id pub-id-type="pmid">4216269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terrier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Karras</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kahn</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Le Guenno</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Marie</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Benarous</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lacraz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Diot</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hermine</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>de Saint-Martin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cath&#x000e9;bras</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Leblond</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Modiano</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>L&#x000e9;ger</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Mariette</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Senet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Plaisier</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Saadoun</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cacoub</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>92</volume>
            <issue>2</issue>
            <fpage>61</fpage>
            <page-range>61-68</page-range>
            <pub-id pub-id-type="pmid">23429354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Musset</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Diemert</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Taibi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Thi Huong Du</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cacoub</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Leger</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Boissy</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gaillard</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Galli</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Characterization of cryoglobulins by immunoblotting.</article-title>
            <source>Clin Chem</source>
            <year>1992</year>
            <month>Jun</month>
            <volume>38</volume>
            <issue>6</issue>
            <fpage>798</fpage>
            <page-range>798-802</page-range>
            <pub-id pub-id-type="pmid">1597004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aguiar</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Faria-Janes</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Garcia-Brandes</surname>
                <given-names>GI</given-names>
              </name>
              <name>
                <surname>Takemi-Emori</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ferraz</surname>
                <given-names>MLG</given-names>
              </name>
              <name>
                <surname>Andrade</surname>
                <given-names>LEC</given-names>
              </name>
              <name>
                <surname>de Souza</surname>
                <given-names>AWS</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of cryoglobulinemia and cryoglobulinemic vasculitis in chronically HCV-infected Brazilian patients.</article-title>
            <source>Ann Hepatol</source>
            <year>2019</year>
            <season>Sep-Oct</season>
            <volume>18</volume>
            <issue>5</issue>
            <fpage>685</fpage>
            <page-range>685-692</page-range>
            <pub-id pub-id-type="pmid">31167733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Greco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Longombardo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Palla</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Moretti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marzo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fosella</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Pasero</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bombardieri</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Antibodies against hepatitis C virus in mixed cryoglobulinemia patients.</article-title>
            <source>Infection</source>
            <year>1991</year>
            <season>Nov-Dec</season>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>417</fpage>
            <page-range>417-20</page-range>
            <pub-id pub-id-type="pmid">1726164</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terrier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Marie</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lacraz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Belenotti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bonnet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chiche</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Graffin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hot</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kahn</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Michel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Quemeneur</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>de Saint-Martin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hermine</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>L&#x000e9;ger</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Mariette</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Senet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Plaisier</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cacoub</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature.</article-title>
            <source>J Autoimmun</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>65</volume>
            <fpage>74</fpage>
            <page-range>74-81</page-range>
            <pub-id pub-id-type="pmid">26320984</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Casato</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de Rosa</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Pucillo</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Ilardi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>di Vico</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zorzin</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Sorgi</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Fiaschetti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Coviello</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lagan&#x000e0;</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fiorilli</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Mixed cryoglobulinemia secondary to visceral Leishmaniasis.</article-title>
            <source>Arthritis Rheum</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>42</volume>
            <issue>9</issue>
            <fpage>2007</fpage>
            <page-range>2007-11</page-range>
            <pub-id pub-id-type="pmid">10513819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Galli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Invernizzi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chemotti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Monti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gasparro</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Caredda</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Negri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moroni</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Cryoglobulins and infectious diseases.</article-title>
            <source>Ric Clin Lab</source>
            <year>1986</year>
            <season>Apr-Jun</season>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>301</fpage>
            <page-range>301-13</page-range>
            <pub-id pub-id-type="pmid">3097790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lazzerini</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Cusi</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Selvi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Capecchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moscadelli</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Migliacci</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Finizola</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Laghi-Pasini</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection.</article-title>
            <source>Joint Bone Spine</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>85</volume>
            <issue>1</issue>
            <fpage>129</fpage>
            <page-range>129-130</page-range>
            <pub-id pub-id-type="pmid">28062379</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hasegawa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hayami</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hoshino</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Suwabe</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sumida</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mise</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ueno</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamanouchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sawa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ohashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fujii</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takaichi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ubara</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Cryoglobulinemic vasculitis with primary Sj&#x000f6;gren's syndrome: A case report.</article-title>
            <source>Mod Rheumatol</source>
            <year>2018</year>
            <month>May</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>570</fpage>
            <page-range>570-574</page-range>
            <pub-id pub-id-type="pmid">26743943</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giuggioli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Manfredi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Colaci</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Manzini</surname>
                <given-names>CU</given-names>
              </name>
              <name>
                <surname>Antonelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ferri</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature.</article-title>
            <source>Autoimmun Rev</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>12</volume>
            <issue>11</issue>
            <fpage>1058</fpage>
            <page-range>1058-63</page-range>
            <pub-id pub-id-type="pmid">23806565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horino</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hamada-Ode</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ichii</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Terada</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Overlapping Syndrome of Systemic Scleroderma and Cryoglobulinemic Vasculitis.</article-title>
            <source>Am J Med</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>132</volume>
            <issue>6</issue>
            <fpage>e589</fpage>
            <page-range>e589-e590</page-range>
            <pub-id pub-id-type="pmid">30831066</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nozawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kaneko</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Itoh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Katsura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Noguchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Takasaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ogawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Takamori</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sekigawa</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Synchronous malignant B-cell lymphoma and gastric tubular adenocarcinoma associated with paraneoplastic cutaneous vasculitis: hypereosinophilic syndrome with mixed cryoglobulinemia is an important sign of paraneoplastic syndrome.</article-title>
            <source>Rare Tumors</source>
            <year>2009</year>
            <month>Dec</month>
            <day>28</day>
            <volume>1</volume>
            <issue>2</issue>
            <fpage>e42</fpage>
            <pub-id pub-id-type="pmid">21139921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zignego</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Pileri</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Cryoglobulins.</article-title>
            <source>J Clin Pathol</source>
            <year>2002</year>
            <month>Jan</month>
            <volume>55</volume>
            <issue>1</issue>
            <fpage>4</fpage>
            <page-range>4-13</page-range>
            <pub-id pub-id-type="pmid">11825916</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramos-Casals</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Medina</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jara</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Rosas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Calvo-Alen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brito-Zer&#x000f3;n</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Forns</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-Tapias</surname>
                <given-names>JM</given-names>
              </name>
              <collab>HISPAMEC Study Group</collab>
            </person-group>
            <article-title>Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry).</article-title>
            <source>J Rheumatol</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>36</volume>
            <issue>7</issue>
            <fpage>1442</fpage>
            <page-range>1442-8</page-range>
            <pub-id pub-id-type="pmid">19369460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gatta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giannini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lampertico</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pontisso</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Quarta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zignego</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Atzeni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sarzi-Puttini</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Hepatotropic viruses: new insights in pathogenesis and treatment.</article-title>
            <source>Clin Exp Rheumatol</source>
            <year>2008</year>
            <season>Jan-Feb</season>
            <volume>26</volume>
            <issue>1 Suppl 48</issue>
            <fpage>S33</fpage>
            <page-range>S33-8</page-range>
            <pub-id pub-id-type="pmid">18570752</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Payet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Livartowski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kavian</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chandesris</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Dupin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wallet</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Karras</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Salliot</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Suarez</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Avet-Loiseau</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Alyanakian</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Nawakil</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tamburini</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Roux</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bouscary</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sparsa</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Type I cryoglobulinemia in multiple myeloma, a rare entity: analysis of clinical and biological characteristics of seven cases and review of the literature.</article-title>
            <source>Leuk Lymphoma</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>54</volume>
            <issue>4</issue>
            <fpage>767</fpage>
            <page-range>767-77</page-range>
            <pub-id pub-id-type="pmid">22385269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pawlotsky</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ben Yahia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Andre</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Voisin</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Intrator</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Roudot-Thoraval</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Deforges</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Duvoux</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zafrani</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Duval</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Immunological disorders in C virus chronic active hepatitis: a prospective case-control study.</article-title>
            <source>Hepatology</source>
            <year>1994</year>
            <month>Apr</month>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>841</fpage>
            <page-range>841-8</page-range>
            <pub-id pub-id-type="pmid">8138255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strait</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Posgai</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Mahler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barasa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jacob</surname>
                <given-names>CO</given-names>
              </name>
              <name>
                <surname>K&#x000f6;hl</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ehlers</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stringer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shanmukhappa</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Witte</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hossain</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Khodoun</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Herr</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Finkelman</surname>
                <given-names>FD</given-names>
              </name>
            </person-group>
            <article-title>IgG1 protects against renal disease in a mouse model of cryoglobulinaemia.</article-title>
            <source>Nature</source>
            <year>2015</year>
            <month>Jan</month>
            <day>22</day>
            <volume>517</volume>
            <issue>7535</issue>
            <fpage>501</fpage>
            <page-range>501-4</page-range>
            <pub-id pub-id-type="pmid">25363774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gragnani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Piluso</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giannini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Caini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fognani</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Monti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Petrarca</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ranieri</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Razzolini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Froio</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Laffi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zignego</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc&#x003b3; receptors.</article-title>
            <source>Arthritis Rheum</source>
            <year>2011</year>
            <month>May</month>
            <volume>63</volume>
            <issue>5</issue>
            <fpage>1446</fpage>
            <page-range>1446-51</page-range>
            <pub-id pub-id-type="pmid">21538321</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sansonno</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cornacchiulo</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Iacobelli</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Di Stefano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lospalluti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dammacco</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia.</article-title>
            <source>Hepatology</source>
            <year>1995</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>305</fpage>
            <page-range>305-12</page-range>
            <pub-id pub-id-type="pmid">7843698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mascia</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Cryoglobulinemic vasculitis.</article-title>
            <source>Curr Opin Rheumatol</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-63</page-range>
            <pub-id pub-id-type="pmid">16344620</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levine</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Gota</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fessler</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Calabrese</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus.</article-title>
            <source>J Rheumatol</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>1164</fpage>
            <page-range>1164-7</page-range>
            <pub-id pub-id-type="pmid">15940780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Landau</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Saadoun</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Halfon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Martinot-Peignoux</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marcellin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fois</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cacoub</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.</article-title>
            <source>Arthritis Rheum</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>58</volume>
            <issue>2</issue>
            <fpage>604</fpage>
            <page-range>604-11</page-range>
            <pub-id pub-id-type="pmid">18240235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berera</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gomez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dholaria</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Arosemena</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Ladino-Avellaneda</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Barisoni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bhamidimarri</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>A Rare Case of Hepatitis C-Associated Cryoglobulinemic Duodenal Vasculitis.</article-title>
            <source>ACG Case Rep J</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>3</volume>
            <issue>4</issue>
            <fpage>e134</fpage>
            <pub-id pub-id-type="pmid">27807586</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonacci</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lens</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mari&#x000f1;o</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Londo&#x000f1;o</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Rodriguez-Tajes</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-Tapias</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ramos-Casals</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez-Rodr&#x000ed;guez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Forns</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure.</article-title>
            <source>Gastroenterology</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>155</volume>
            <issue>2</issue>
            <fpage>311</fpage>
            <page-range>311-315.e6</page-range>
            <pub-id pub-id-type="pmid">29705529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Visentini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fiorilli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Casato</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Persistence of Pathogenic B-Cell Clones and Relapse of Cryoglobulinemic Vasculitis in HCV-Cured Patients.</article-title>
            <source>Gastroenterology</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>156</volume>
            <issue>1</issue>
            <fpage>291</fpage>
            <pub-id pub-id-type="pmid">30315773</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hegazy</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Allam</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Hussein</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Zoheir</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Quartuccio</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>El-Khamisy</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Ragab</surname>
                <given-names>G</given-names>
              </name>
              <collab>Mediterranean Consortium for the study of Cryoglobulinemic Vasculitis</collab>
            </person-group>
            <article-title>Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs.</article-title>
            <source>EBioMedicine</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>35</volume>
            <fpage>106</fpage>
            <page-range>106-113</page-range>
            <pub-id pub-id-type="pmid">30139628</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kazandjieva</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Antonov</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kamarashev</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tsankov</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Acrally distributed dermatoses: Vascular dermatoses (purpura and vasculitis).</article-title>
            <source>Clin Dermatol</source>
            <year>2017</year>
            <season>Jan-Feb</season>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>68</fpage>
            <page-range>68-80</page-range>
            <pub-id pub-id-type="pmid">27938815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agnello</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>A role for hepatitis C virus infection in type II cryoglobulinemia.</article-title>
            <source>N Engl J Med</source>
            <year>1992</year>
            <month>Nov</month>
            <day>19</day>
            <volume>327</volume>
            <issue>21</issue>
            <fpage>1490</fpage>
            <page-range>1490-5</page-range>
            <pub-id pub-id-type="pmid">1383822</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agnello</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Abel</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia.</article-title>
            <source>Arthritis Rheum</source>
            <year>1997</year>
            <month>Nov</month>
            <volume>40</volume>
            <issue>11</issue>
            <fpage>2007</fpage>
            <page-range>2007-15</page-range>
            <pub-id pub-id-type="pmid">9365090</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spatola</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Generali</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Angelini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Badalamenti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Selmi</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>HCV-negative mixed cryoglobulinemia and kidney involvement: in-depth review on physiopathological and histological bases.</article-title>
            <source>Clin Exp Med</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>465</fpage>
            <page-range>465-471</page-range>
            <pub-id pub-id-type="pmid">29956004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matignon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cacoub</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Colombat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saadoun</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Brocheriou</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mougenot</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Roudot-Thoraval</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vanhille</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Moranne</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Hachulla</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hatron</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Fermand</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Fakhouri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ronco</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Plaisier</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Grimbert</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infection.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>88</volume>
            <issue>6</issue>
            <fpage>341</fpage>
            <page-range>341-348</page-range>
            <pub-id pub-id-type="pmid">19910748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Retamozo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>D&#x000ed;az-Lagares</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bosch</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Bov&#x000e9;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brito-Zer&#x000f3;n</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Yag&#x000fc;e</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Forns</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Cid</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Ramos-Casals</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>92</volume>
            <issue>5</issue>
            <fpage>273</fpage>
            <page-range>273-284</page-range>
            <pub-id pub-id-type="pmid">23974248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin-Bouyer</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>[Data concerning venereal diseases in metropolitan France for the year 1966].</article-title>
            <source>Bull Inst Natl Sante Rech Med</source>
            <year>1967</year>
            <season>Sep-Oct</season>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>1021</fpage>
            <page-range>1021-55</page-range>
            <pub-id pub-id-type="pmid">5632353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanmugarajah</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hussain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Monoclonal cryoglobulinemia with extensive gangrene of all four extremities--a case report.</article-title>
            <source>Angiology</source>
            <year>2000</year>
            <month>May</month>
            <volume>51</volume>
            <issue>5</issue>
            <fpage>431</fpage>
            <page-range>431-4</page-range>
            <pub-id pub-id-type="pmid">10826861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meltzer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Franklin</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Elias</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>McCluskey</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity.</article-title>
            <source>Am J Med</source>
            <year>1966</year>
            <month>Jun</month>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>837</fpage>
            <page-range>837-56</page-range>
            <pub-id pub-id-type="pmid">4956871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sebastiani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Giuggioli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cazzato</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Longombardo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Antonelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Puccini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Michelassi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zignego</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients.</article-title>
            <source>Semin Arthritis Rheum</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>355</fpage>
            <page-range>355-74</page-range>
            <pub-id pub-id-type="pmid">15190522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ammendola</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sampaolo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ambrosone</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ammendola</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ciccone</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Migliaresi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Di Iorio</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: electrophysiologic follow-up study.</article-title>
            <source>Muscle Nerve</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>382</fpage>
            <page-range>382-5</page-range>
            <pub-id pub-id-type="pmid">15515001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cacoub</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Saadoun</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Limal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>L&#x000e9;ger</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Maisonobe</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications.</article-title>
            <source>AIDS</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>19 Suppl 3</volume>
            <fpage>S128</fpage>
            <page-range>S128-34</page-range>
            <pub-id pub-id-type="pmid">16251808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Casato</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saadoun</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Marchetti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Limal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Picq</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pantano</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Galanaud</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cianci</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Duhaut</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Piette</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Fiorilli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cacoub</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests.</article-title>
            <source>J Rheumatol</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>484</fpage>
            <page-range>484-8</page-range>
            <pub-id pub-id-type="pmid">15742440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cavalli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Berti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fragasso</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>De Cobelli</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Hypertrophic cardiomyopathy secondary to hepatitis C virus-related vasculitis.</article-title>
            <source>J Cardiovasc Med (Hagerstown)</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>17 Suppl 2</volume>
            <fpage>e156</fpage>
            <page-range>e156-e157</page-range>
            <pub-id pub-id-type="pmid">24979124</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Vita</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Treatment of mixed cryoglobulinemia: a rheumatology perspective.</article-title>
            <source>Clin Exp Rheumatol</source>
            <year>2011</year>
            <season>Jan-Feb</season>
            <volume>29</volume>
            <issue>1 Suppl 64</issue>
            <fpage>S99</fpage>
            <page-range>S99-103</page-range>
            <pub-id pub-id-type="pmid">21586203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terrier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Krastinova</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Marie</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Launay</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lacraz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Belenotti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>de Saint-Martin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Quemeneur</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Huart</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bonnet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Le Guenno</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kahn</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Hinschberger</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Rullier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Diot</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lazaro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bridoux</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Z&#x000e9;none</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Carrat</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hermine</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>L&#x000e9;ger</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Mariette</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Senet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Plaisier</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cacoub</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey.</article-title>
            <source>Blood</source>
            <year>2012</year>
            <month>Jun</month>
            <day>21</day>
            <volume>119</volume>
            <issue>25</issue>
            <fpage>5996</fpage>
            <page-range>5996-6004</page-range>
            <pub-id pub-id-type="pmid">22474249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koukoulaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abeygunasekara</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Jayne</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>213</fpage>
            <page-range>213-6</page-range>
            <pub-id pub-id-type="pmid">15632353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mukhtyar</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Guillevin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cid</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Dasgupta</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>de Groot</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hauser</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hellmich</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jayne</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kallenberg</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Merkel</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Raspe</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Salvarani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Stegeman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Watts</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Westman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Witter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yazici</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Luqmani</surname>
                <given-names>R</given-names>
              </name>
              <collab>European Vasculitis Study Group</collab>
            </person-group>
            <article-title>EULAR recommendations for the management of primary small and medium vessel vasculitis.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>68</volume>
            <issue>3</issue>
            <fpage>310</fpage>
            <page-range>310-7</page-range>
            <pub-id pub-id-type="pmid">18413444</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ostojic</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Cryoglobulinemic vasculitis in systemic sclerosis successfully treated with mycophenolate mofetil.</article-title>
            <source>Rheumatol Int</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>145</fpage>
            <page-range>145-7</page-range>
            <pub-id pub-id-type="pmid">23271426</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cacoub</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Si Ahmed</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Ferfar</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Pol</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thabut</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hezode</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alric</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Comarmond</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ragab</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Quartuccio</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hegazy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Poynard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Resche Rigon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saadoun</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis.</article-title>
            <source>Clin Gastroenterol Hepatol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>518</fpage>
            <page-range>518-526</page-range>
            <pub-id pub-id-type="pmid">29857143</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saadoun</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Thibault</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Si Ahmed</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Alric</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mallet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guillaud</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Izzedine</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Plaisier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fontaine</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Costopoulos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Le Garff-Tavernier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hezode</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pol</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Musset</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Poynard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cacoub</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>75</volume>
            <issue>10</issue>
            <fpage>1777</fpage>
            <page-range>1777-82</page-range>
            <pub-id pub-id-type="pmid">26567178</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>El-Haddad</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Almuallim</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alshaiki</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Obaid</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Almoallim</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Systematic review of the role of rituximab in treatment of antineutrophil cytoplasmic autoantibody-associated vasculitis, hepatitis C virus-related cryoglobulinemic vasculitis, Henoch-Sch&#x000f6;nlein purpura, ankylosing spondylitis, and Raynaud's phenomenon.</article-title>
            <source>Open Access Rheumatol</source>
            <year>2017</year>
            <volume>9</volume>
            <fpage>201</fpage>
            <page-range>201-214</page-range>
            <pub-id pub-id-type="pmid">29290695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dammacco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tucci</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Lauletta</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gatti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>De Re</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Conteduca</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sansonno</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Russi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mariggi&#x000f2;</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Chironna</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sansonno</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.</article-title>
            <source>Blood</source>
            <year>2010</year>
            <month>Jul</month>
            <day>22</day>
            <volume>116</volume>
            <issue>3</issue>
            <fpage>343</fpage>
            <page-range>343-53</page-range>
            <pub-id pub-id-type="pmid">20308602</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saadoun</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Resche Rigon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sene</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Terrier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Karras</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Perard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schoindre</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Copp&#x000e9;r&#x000e9;</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Blanc</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Musset</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Piette</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Rosenzwajg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cacoub</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.</article-title>
            <source>Blood</source>
            <year>2010</year>
            <month>Jul</month>
            <day>22</day>
            <volume>116</volume>
            <issue>3</issue>
            <fpage>326</fpage>
            <page-range>326-34; quiz 504-5</page-range>
            <pub-id pub-id-type="pmid">20439619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sneller</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Langford</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.</article-title>
            <source>Arthritis Rheum</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>64</volume>
            <issue>3</issue>
            <fpage>835</fpage>
            <page-range>835-42</page-range>
            <pub-id pub-id-type="pmid">22147444</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Vita</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Quartuccio</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Isola</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mazzaro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Scaini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lenzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Campanini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Naclerio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tavoni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pietrogrande</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mascia</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Masolini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zabotti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maset</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Roccatello</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zignego</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Pioltelli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gabrielli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Filippini</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Perrella</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Migliaresi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Galli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bombardieri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Monti</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.</article-title>
            <source>Arthritis Rheum</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>64</volume>
            <issue>3</issue>
            <fpage>843</fpage>
            <page-range>843-53</page-range>
            <pub-id pub-id-type="pmid">22147661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sise</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Bloom</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Wisocky</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Gustafson</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Lundquist</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Steele</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Thiim</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Hashemi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Thadhani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents.</article-title>
            <source>Hepatology</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>63</volume>
            <issue>2</issue>
            <fpage>408</fpage>
            <page-range>408-17</page-range>
            <pub-id pub-id-type="pmid">26474537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Qu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Type I cryoglobulinemic vasulitis with eosinophilia: A case report and literature review.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>98</volume>
            <issue>28</issue>
            <fpage>e16382</fpage>
            <pub-id pub-id-type="pmid">31305439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramirez</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Campochiaro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Salmaggi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pagliula</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>D'Aliberti</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Marcatti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tresoldi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Praderio</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Bortezomib in type I cryoglobulinemic vasculitis: are we acting too late?</article-title>
            <source>Intern Med</source>
            <year>2015</year>
            <volume>54</volume>
            <issue>9</issue>
            <fpage>1119</fpage>
            <page-range>1119-23</page-range>
            <pub-id pub-id-type="pmid">25948361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>XH</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>MX</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Concomitant cryoglobulinemic vasculitis and cold agglutinin disease successfully treated with bortezomib: A case report.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>98</volume>
            <issue>4</issue>
            <fpage>e14201</fpage>
            <pub-id pub-id-type="pmid">30681592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spizzo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mitterer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gunsilius</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Bortezomib for the treatment of refractory Type-1 cryoglobulinaemia.</article-title>
            <source>Br J Haematol</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>150</volume>
            <issue>2</issue>
            <fpage>235</fpage>
            <page-range>235-7</page-range>
            <pub-id pub-id-type="pmid">20346005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mazzaro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dal Maso</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Urraro</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mauro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Castelnovo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Casarin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Monti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gattei</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Zignego</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Pozzato</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Hepatitis B virus related cryoglobulinemic vasculitis: A multicentre open label study from the Gruppo Italiano di Studio delle Crioglobulinemie - GISC.</article-title>
            <source>Dig Liver Dis</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>48</volume>
            <issue>7</issue>
            <fpage>780</fpage>
            <page-range>780-4</page-range>
            <pub-id pub-id-type="pmid">27106525</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pasquet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Combarnous</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Macgregor</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Coppere</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mausservey</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ninet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hot</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Safety and efficacy of rituximab treatment for vasculitis in hepatitis B virus-associated type II cryoglobulinemia: a case report.</article-title>
            <source>J Med Case Rep</source>
            <year>2012</year>
            <month>Jan</month>
            <day>27</day>
            <volume>6</volume>
            <fpage>39</fpage>
            <pub-id pub-id-type="pmid">22284897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oykhman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Aaron</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Multiorgan Failure From Cryoglobulinemic Vasculitis Following Intravenous Immunoglobulin Replacement Therapy.</article-title>
            <source>J Clin Rheumatol</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>22</volume>
            <issue>8</issue>
            <fpage>441</fpage>
            <page-range>441-443</page-range>
            <pub-id pub-id-type="pmid">27870771</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chandesris</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Gayet</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schleinitz</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Doudier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Harl&#x000e9;</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Kaplanski</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemia.</article-title>
            <source>Rheumatology (Oxford)</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>43</volume>
            <issue>4</issue>
            <fpage>532</fpage>
            <page-range>532-3</page-range>
            <pub-id pub-id-type="pmid">15024144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bartolucci</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ramanoelina</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mahr</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Godmer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Le Hello</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Guillevin</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients.</article-title>
            <source>Rheumatology (Oxford)</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>41</volume>
            <issue>10</issue>
            <fpage>1126</fpage>
            <page-range>1126-32</page-range>
            <pub-id pub-id-type="pmid">12364631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Della Rossa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marchi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Catarsi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tavoni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bombardieri</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Mixed cryoglobulinemia and mortality: a review of the literature.</article-title>
            <source>Clin Exp Rheumatol</source>
            <year>2008</year>
            <season>Sep-Oct</season>
            <volume>26</volume>
            <issue>5 Suppl 51</issue>
            <fpage>S105</fpage>
            <page-range>S105-8</page-range>
            <pub-id pub-id-type="pmid">19026151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guillevin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lhote</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gayraud</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jarrousse</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lortholary</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Thibult</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Casassus</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1996</year>
            <month>Jan</month>
            <volume>75</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-28</page-range>
            <pub-id pub-id-type="pmid">8569467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terrier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Semoun</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Saadoun</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>S&#x000e8;ne</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Resche-Rigon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cacoub</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis.</article-title>
            <source>Arthritis Rheum</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>63</volume>
            <issue>6</issue>
            <fpage>1748</fpage>
            <page-range>1748-57</page-range>
            <pub-id pub-id-type="pmid">21400476</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Calle Toro</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Davalos</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Charry</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Arrunategi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Tobon</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Hepatic and Mesenteric Vasculitis as Presenting Manifestation of Mixed Cryoglobulinemia Related to Chronic Hepatitis C Virus Infection in a Female Patient.</article-title>
            <source>J Clin Rheumatol</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>212</fpage>
            <page-range>212-4</page-range>
            <pub-id pub-id-type="pmid">27219310</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terrier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Carrat</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Krastinova</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Marie</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Launay</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lacraz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Belenotti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>de Saint Martin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Quemeneur</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Huart</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bonnet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Le Guenno</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kahn</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Hinschberger</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Rullier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hummel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Diot</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pagnoux</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lzaro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bridoux</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zenone</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hermine</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Leger</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Mariette</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Senet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Plaisier</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cacoub</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>72</volume>
            <issue>3</issue>
            <fpage>374</fpage>
            <page-range>374-80</page-range>
            <pub-id pub-id-type="pmid">22586172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zaidan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Terrier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pozdzik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Frouget</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rioux-Leclercq</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Combe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lepreux</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hummel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>No&#x000eb;l</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Marie</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Legallicier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fran&#x000e7;ois</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Huart</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Launay</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kaplanski</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bridoux</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vanhille</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Makdassi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Augusto</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Rouvier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Karras</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jouanneau</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Verpont</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Callard</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Carrat</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hermine</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>L&#x000e9;ger</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Mariette</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Senet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Saadoun</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ronco</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Broch&#x000e9;riou</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cacoub</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Plaisier</surname>
                <given-names>E</given-names>
              </name>
              <collab>CryoVas study group</collab>
            </person-group>
            <article-title>Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN.</article-title>
            <source>J Am Soc Nephrol</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>1213</fpage>
            <page-range>1213-24</page-range>
            <pub-id pub-id-type="pmid">26260165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sidana</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rajkumar</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Dispenzieri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lacy</surname>
                <given-names>MQ</given-names>
              </name>
              <name>
                <surname>Gertz</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Buadi</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Hayman</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Dingli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kapoor</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gonsalves</surname>
                <given-names>WI</given-names>
              </name>
              <name>
                <surname>Go</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Hwa</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fonder</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Hobbs</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Zeldenrust</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Lust</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kyle</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia.</article-title>
            <source>Am J Hematol</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>92</volume>
            <issue>7</issue>
            <fpage>668</fpage>
            <page-range>668-673</page-range>
            <pub-id pub-id-type="pmid">28370486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Monti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pioltelli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Saccardo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Campanini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Candela</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cavallero</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>De Vita</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ferri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mazzaro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Migliaresi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ossi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pietrogrande</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gabrielli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Galli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Invernizzi</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias.</article-title>
            <source>Arch Intern Med</source>
            <year>2005</year>
            <month>Jan</month>
            <day>10</day>
            <volume>165</volume>
            <issue>1</issue>
            <fpage>101</fpage>
            <page-range>101-5</page-range>
            <pub-id pub-id-type="pmid">15642884</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arandjelovic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bonaci-Nikolic</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Peric-Popadic</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tomic-Spiric</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bolpacic</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Raskovic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Andrejevic</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>HCV related severe cryoglobulinemic vasculitis treated with plasma exchange and rituximab: case report and literature review.</article-title>
            <source>J Infect Dev Ctries</source>
            <year>2017</year>
            <month>Jun</month>
            <day>01</day>
            <volume>11</volume>
            <issue>5</issue>
            <fpage>431</fpage>
            <page-range>431-436</page-range>
            <pub-id pub-id-type="pmid">30943182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-42398.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Odish</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Beben</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Daniels</surname>
                <given-names>LB</given-names>
              </name>
            </person-group>
            <article-title>False-positive Troponin I Assay elevation due to occult Mixed Cryoglobulinemic Vasculitis.</article-title>
            <source>Rev Cardiovasc Med</source>
            <year>2018</year>
            <month>Jun</month>
            <day>30</day>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>73</fpage>
            <page-range>73-75</page-range>
            <pub-id pub-id-type="pmid">31032606</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
